The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 18, 2020
Filed:
Jun. 28, 2017
Applicant:
Doris Maria Hexsel, Porto Alegre, BR;
Inventor:
Doris Maria Hexsel, Porto Alegre, BR;
Assignee:
Other;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/498 (2006.01); A61K 9/00 (2006.01); A61K 8/02 (2006.01); A61K 8/04 (2006.01); A61K 8/49 (2006.01); A61P 7/00 (2006.01); A61Q 17/04 (2006.01); A61P 17/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/498 (2013.01); A61K 8/022 (2013.01); A61K 8/042 (2013.01); A61K 8/494 (2013.01); A61K 9/0014 (2013.01); A61P 17/00 (2018.01); A61Q 17/04 (2013.01); A61K 45/06 (2013.01); A61K 2800/10 (2013.01); A61K 2800/43 (2013.01);
Abstract
The present invention belongs, in a general manner to the technological field of the pharmaceutical industry and relates, more specifically, to one or more compositions of second use to be destined for the treatment of melasma. The present invention relates to the use of substances belonging to the group of alpha-adrenergic receptor agonists, in different variable concentrations, for treating conditions of melasma upon human skin. Furthermore, the present invention discloses pharmaceutical compositions, the latter being associated or not with other compounds or methods of treatment, to be utilised for the treatment of melasma.